在儿科患者的抗凝血药物
Marilyn J Manco-Johnson1, Aparna Annam2, Timothy Schardt3
1Department of Pediatrics, Hemophilia & Thrombosis Center, University of Colorado Anschutz Medical Campus, Aurora, CO.
Techniques in vascular and interventional radiology
|August 21, 2024
概括
儿童抗血栓剂,包括抗凝固剂和抗血小板药物,越来越多地使用. 本综述详细介绍了它们的机制,安全性和儿童用剂量.
科学领域:
- 儿科药理学 儿科药理学
- 血液学 血液学 血液学
- 心血管医学 心血管医学
背景情况:
- 在儿科患者中,抗血栓剂的使用正在增加.
- 增加对临床试验的纳入,为儿童提供了更多的安全性和有效性数据.
- 药物包括抗凝剂 (间接,直接的血栓/XA因子抑制剂) 和抗血小板疗法.
研究的目的:
- 审查儿科患者使用的抗血栓剂.
- 详细说明作用机制,施用,清除和半衰期.
- 讨论抗凝治疗中的抗凝治疗.
主要方法:
- 对当前儿科使用的抗血栓剂的文献综述.
- 对药物类别,机制,药理动力学和安全性概况的分析.
- 讨论临床指示和剂量考虑.
主要成果:
- 有不同的抗血栓类存在,具有独特的特性.
- 疗效和持续时间取决于指示和患者的稳定性.
- 药物动力学的变化需要小心对儿童给予剂量.
结论:
- 了解药物特异性对于安全有效的儿科使用至关重要.
- 个性化治疗方法对于最佳结果至关重要.
- 进一步的研究可能会完善儿童的抗血栓策略.
相关概念视频
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
654
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
654
01:24Disorders of Hemostasis
756
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
756